Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1981 Apr;19(4):545–548. doi: 10.1128/aac.19.4.545

Penetrance of nafcillin into human ventricular fluid: correlation with ventricular pleocytosis and glucose levels.

R Yogev, W E Schultz, S B Rosenman
PMCID: PMC181474  PMID: 7247377

Abstract

Fourteen hydrocephalic pediatric patients with suspected shunt infections were studied for penetrance of nafcillin into the ventricular fluid after intravenous administration. In seven patients with bacterial ventriculitis, the concentration of nafcillin in ventricular fluid was 0.8 to 20.4% of the peak concentration in serum. In the remaining seven patients without bacterial ventriculitis, ventricular fluid levels ranged between less than or equal to 0.02 to 4% of peak serum concentrations. Although the degree of pleocytosis correlated poorly with penetrance, ventricular fluid glucose levels correlated inversely with penetrance of nafcillin (r = -0.7275, P less than 0.001).

Full text

PDF
545

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. DOUTHWAITE A. H., TRAFFORD J. A., McGILL D. A., EVANS I. E. Methicillin. Br Med J. 1961 Jul 1;2(5243):6–8. doi: 10.1136/bmj.2.5243.6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Feldman W. E., Nelson J. D., Stanberry L. R. Clinical and pharmacokinetic evaluation of nafcillin in infants and children. J Pediatr. 1978 Dec;93(6):1029–1033. doi: 10.1016/s0022-3476(78)81251-7. [DOI] [PubMed] [Google Scholar]
  3. Fossieck B. E., Jr, Kane J. G., Diaz C. R., Parker R. H. Nafcillin entry into human cerebrospinal fluid. Antimicrob Agents Chemother. 1977 Jun;11(6):965–967. doi: 10.1128/aac.11.6.965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. KLEIN J. O., FINLAND M. THE NEW PENICILINS. N Engl J Med. 1963 Nov 7;269:1019–CONTD. doi: 10.1056/NEJM196311072691907. [DOI] [PubMed] [Google Scholar]
  5. Kancir L. M., Tuazon C. U., Cardella T. A., Sheagren J. N. Adverse reactions to methicillin and nafcillin during treatment of serious Staphylococcus aureaus infections. Arch Intern Med. 1978 Jun;138(6):909–911. [PubMed] [Google Scholar]
  6. Kane J. G., Parker R. H., Jordan G. W., Hoeprich P. D. Nafcillin concentration in cerebrospinal fluid during treatment of staphylococcal infections. Ann Intern Med. 1977 Sep;87(3):309–311. doi: 10.7326/0003-4819-87-3-309. [DOI] [PubMed] [Google Scholar]
  7. Oppenheimer S., Beaty H. N., Petersdorf R. G. Pathogenesis of meningitis. VIII. Cerebrospinal fluid and blood concentrations of methicillin, cephalothin, and cephaloridine in experimental pneumococcal meningitis. J Lab Clin Med. 1969 Apr;73(4):535–543. [PubMed] [Google Scholar]
  8. Ruiz D. E., Warner J. F. Nafcillin treatment of Staphylococcus aureus meningitis. Antimicrob Agents Chemother. 1976 Mar;9(3):554–555. doi: 10.1128/aac.9.3.554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Sabath L. D., Garner C., Wilcox C., Finland M. Susceptibility of Staphylococcus aureus and Staphylococcus epidermidis to 65 antibiotics. Antimicrob Agents Chemother. 1976 Jun;9(6):962–969. doi: 10.1128/aac.9.6.962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Schoenbaum S. C., Gardner P., Shillito J. Infections of cerebrospinal fluid shunts: epidemiology, clinical manifestations, and therapy. J Infect Dis. 1975 May;131(5):543–552. doi: 10.1093/infdis/131.5.543. [DOI] [PubMed] [Google Scholar]
  11. Yogev R., Davis A. T. Neurosurgical shunt infections. A review. Childs Brain. 1980;6(2):74–81. doi: 10.1159/000119888. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES